Transmissible gastroenteritis virus infection induces cell apoptosis via activation of p53 signalling

Journal of General Virology

Volumn 94, Issue PART8, 2013, Pages 1807-1817

  Huang, Yong ^a   Ding, Li ^a   Li, Zhaocai ^a   Dai, Meiling ^a   Zhao, Xiaomin ^a   Li, Wei ^a   Du, Qian ^a   Xu, Xingang ^a   Tong, Dewen ^a  

^a NORTHWEST A F UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; E1A ASSOCIATED P300 PROTEIN; FAS LIGAND; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P53; SERINE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSMISSIBLE GASTROENTERITIS VIRUS; ULTRAVIOLET RADIATION; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; APOPTOSIS; CELL LINE; HOST-PATHOGEN INTERACTIONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SERINE; SIGNAL TRANSDUCTION; SWINE; TRANSMISSIBLE GASTROENTERITIS VIRUS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84880165585     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.051557-0     Document Type: Article

References (41)

1. Austin, D., Baer, A., Lundberg, L., Shafagati, N., Schoonmaker, A., Narayanan, A., Popova, T., Panthier, J. J., Kashanchi, F. & other authors (2012). p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production. PLoS ONE 7, e36327.
2. Bálint, É. & Vousden, K. H. (2001). Activation and activities of the p53 tumour suppressor protein. Br J Cancer 85, 1813-1823.
3. Banerjee, S., Narayanan, K., Mizutani, T. & Makino, S. (2002). Murine coronavirus replication-induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and virus replication in cultured cells. J Virol 76, 5937-5948.
4. Barber, G. N. (2001). Host defense, viruses and apoptosis. Cell Death Differ 8, 113-126.
5. Carstens, E. B. (2010). Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2009). Arch Virol 155, 133-146.
6. Chen, J. & Li, Q. (2011). Life and death of transcriptional co-activator p300. Epigenetics 6, 957-961.
7. Chen, C. J., Sugiyama, K., Kubo, H., Huang, C. & Makino, S. (2004). Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/ G1 phase. J Virol 78, 10410-10419.
8. Cruz, J. L., Sola, I., Becares, M., Alberca, B., Plana, J., Enjuanes, L. & Zuñiga, S. (2011). Coronavirus gene 7 counteracts host defenses and modulates virus virulence. PLoS Pathog 7, e1002090.
9. Desloges, N., Schubert, C., Wolff, M. H. & Rahaus, M. (2008). Varicella-zoster virus infection induces the secretion of interleukin-8. Med Microbiol Immunol (Berl) 197, 277-284.
10. Ding, L., Xu, X., Huang, Y., Li, Z., Zhang, K., Chen, G., Yu, G., Wang, Z., Li, W. & Tong, D. (2012). Transmissible gastroenteritis virus infection induces apoptosis through FasLand mitochondria-mediated pathways. Vet Microbiol 158, 12-22.
11. Eléouet, J. F., Chilmonczyk, S., Besnardeau, L. & Laude, H. (1998). Transmissible gastroenteritis coronavirus induces programmed cell death in infected cells through a caspase-dependent pathway. J Virol 72, 4918-4924.
12. Eléouet, J. F., Slee, E. A., Saurini, F., Castagné, N., Poncet, D., Garrido, C., Solary, E. & Martin, S. J. (2000). The viral nucleocapsid protein of transmissible gastroenteritis coronavirus (TGEV) is cleaved by caspase6 and -7 during TGEV-induced apoptosis. J Virol 74, 3975-3983.
13. Enjuanes, L. & Van der Zeijst, B. A. M. (1995). Molecular basis of transmissible gastroenteritis virus epidemiology. In The Coronaviridae, pp. 337-376.
14. Edited by S. G. Siddell. New York, NY: Plenum Press. Everett, H. McFadden, G. (1999). Apoptosis: an innate immune response to virus infection. Trends Microbiol 7, 160-165.
15. Gostissa, M., Hofmann, T. G., Will, H. & Del Sal, G. (2003). Regulation of p53 functions: let's meet at the nuclear bodies. Curr Opin Cell Biol 15, 351-357.
16. Grossman, S. R., Perez, M., Kung, A. L., Joseph, M., Mansur, C., Xiao, Z. X., Kumar, S., Howley, P. M. & Livingston, D. M. (1998). p300/ MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell 2, 405-415.
17. Kuribayashi, K., Finnberg, N., Jeffers, J. R., Zambetti, G. P. & ElDeiry, W. S. (2011). The relative contribution of pro-apoptotic p53target genes in the triggering of apoptosis following DNA damage in vitro and in vivo. Cell Cycle 10, 2380-2389.
18. Li, L., Liao, J., Ruland, J., Mak, T. W. & Cohen, S. N. (2001). A TSG101/ MDM2 regulatory loop modulates MDM2 degradation and MDM2/ p53 feedback control. Proc Natl Acad Sci U S A 98, 1619-1624.
19. Li, Z., Xu, X., Huang, Y., Ding, L., Wang, Z., Yu, G., Xu, D., Li, W. & Tong, D. (2012). Swainsonine activates mitochondria-mediated apoptotic pathway in human lung cancer A549 cells and retards the growth of lung cancer xenografts. Int J Biol Sci 8, 394-405.
20. Lin, P. Y., Lee, J. W., Liao, M. H., Hsu, H. Y., Chiu, S. J., Liu, H. J. & Shih, W. L. (2009). Modulation of p53 by mitogen-activated protein kinase pathways and protein kinase C delta during avian reovirus S1133induced apoptosis. Virology 385, 323-334.
21. Lorusso, A., Decaro, N., Schellen, P., Rottier, P. J., Buonavoglia, C., Haijema, B. J. & de Groot, R. J. (2008). Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein. J Virol 82, 10312-10317.
22. Mayo, L. D. & Donner, D. B. (2002). The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem Sci 27, 462-467.
23. Miyashita, T. & Reed, J. C. (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299.
24. Mizutani, T., Fukushi, S., Saijo, M., Kurane, I. & Morikawa, S. (2004). Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells. Biochem Biophys Res Commun 319, 1228-1234.
25. Muñoz-Fontela, C., Macip, S., Martínez-Sobrido, L., Brown, L., Ashour, J., García-Sastre, A., Lee, S. W. & Aaronson, S. A. (2008). Transcriptional role of p53 in interferon-mediated antiviral immunity. J Exp Med 205, 1929-1938.
26. Padhan, K., Minakshi, R., Towheed, M. A. & Jameel, S. (2008). Severe acute respiratory syndrome coronavirus 3a protein activates the mitochondrial death pathway through p38 MAP kinase activation. J Gen Virol 89, 1960-1969.
27. Pampin, M., Simonin, Y., Blondel, B., Percherancier, Y. & Chelbi-Alix, M. K. (2006). Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense. J Virol 80, 8582-8592.
28. Perfettini, J. L., Castedo, M., Nardacci, R., Ciccosanti, F., Boya, P., Roumier, T., Larochette, N., Piacentini, M. & Kroemer, G. (2005). Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. J Exp Med 201, 279-289.
29. Prives, C. & Hall, P. A. (1999). The p53 pathway. J Pathol 187, 112-126.
30. Rahaus, M., Desloges, N. & Wolff, M. H. (2004). Replication of varicella-zoster virus is influenced by the levels of JNK/SAPK and p38/ MAPK activation. J Gen Virol 85, 3529-3540.
31. Reed, L. J. & Muench, H. (1938). A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27, 493-497.
32. Regan, A. D., Cohen, R. D. & Whittaker, G. R. (2009). Activation of p38 MAPK by feline infectious peritonitis virus regulates proinflammatory cytokine production in primary blood-derived feline mononuclear cells. Virology 384, 135-143.
33. Shi, D., Pop, M. S., Kulikov, R., Love, I. M., Kung, A. L. & Grossman, S. R. (2009). CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53. Proc Natl Acad Sci U S A 106, 16275-16280.
34. Sirinarumitr, T., Kluge, J. P. & Paul, P. S. (1998). Transmissible gastroenteritis virus induced apoptosis in swine testes cell cultures. Arch Virol 143, 2471-2485.
35. Smeenk, L., van Heeringen, S. J., Koeppel, M., Gilbert, B., JanssenMegens, E., Stunnenberg, H. G. & Lohrum, M. (2011). Role of p53 serine 46 in p53 target gene regulation. PLoS ONE 6, e17574.
36. Stempin, C. C., Garrido, V. V., Dulgerian, L. R. & Cerbán, F. M. (2008). Cruzipain and SP600125 induce p38 activation, alter NO/arginase balance and favor the survival of Trypanosoma cruzi in macrophages. Acta Trop 106, 119-127.
37. Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., Shibue, T. & other authors (2003). Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 424, 516-523.
38. Wu, G. S. (2004). The functional interactions between the p53 and MAPK signaling pathways. Cancer Biol Ther 3, 156-161.
39. Zarubin, T. & Han, J. (2005). Activation and signaling of the p38 MAP kinase pathway. Cell Res 15, 11-18.
40. Zhong, Y., Tan, Y. W. & Liu, D. X. (2012). Recent progress in studies of arterivirusand coronavirus-host interactions. Viruses 4, 980-1010.
41. Zhou, Q., Zhu, M., Zhang, H., Yi, T., Klena, J. D. & Peng, Y. (2012). Disruption of the p53-p21 pathway inhibits efficiency of the lyticreplication cycle of herpes simplex virus type 2 (HSV-2). Virus Res 169, 91-97.